Mammoth Biosciences Mammoth Biosciences Raises $195M in Two Financing Rounds, Achieves Unicorn Status Premium The company, which now ranks as a startup with a valuation of more than $1 billion, will use the new funds to develop CRISPR-based therapeutics. Mammoth Biosciences, Agilent to Comarket CRISPR-Based SARS-CoV-2 Test The diagnostic is composed of Agilent's Bravo automation workstation and Mammoth's DETECTR BOOST SARS-CoV-2 assay. Mammoth Biosciences Taking Lead Role in DARPA-Funded Development of Pathogen Detection Tech Premium The company's DETECTR disease detection platform will be used to help develop the technology and optimize the CRISPR enzymes used in the point-of-care device. DARPA Awards $36.7M to Six Organizations for Gene Editing-Based Dx, Biosurveillance Tech The contract was awarded under DARPA's Detect It with Gene Editing Technologies program, which aims to create a device to detect at least 10 pathogens. COVID-19 Pandemic Accelerated Development of CRISPR as a Diagnostic Platform in 2020 The pace of development for CRISPR-based infectious disease assays increased as the pandemic progress Nov 18, 2020 Stanford Researchers Combine CRISPR, Microfluidics, Electric Fields for SARS-CoV-2 Dx Premium Oct 29, 2020 Mammoth Bio Signs Commercialization Deal for SARS CoV-2 Test With MilliporeSigma, Hamilton Company Sep 2, 2020 FDA Grants EUAs for MiraDx, Mammoth Biosciences, BayCare Laboratories Molecular Coronavirus Tests Aug 27, 2020 Chinese Researchers Develop CRISPR-Based Isothermal COVID-19 Diagnostic Premium Aug 12, 2020 Mammoth Biosciences Eyes Multiple Applications for Newly Discovered UC Berkeley CRISPR Proteins Premium Jul 31, 2020 NIH Awards $249M to Seven Firms for Rapid Acceleration of COVID-19 Diagnostics Jul 28, 2020 Startup CRISPR Firm Caspr Biotech Developing COVID Dx Using New Extremophile Bacteria Nuclease Premium Jul 10, 2020 FDA Grants EUA for UCSF, Broad Institute, BioSewoom Coronavirus Tests Jul 1, 2020 Sherlock Biosciences, Binx Health Partner to Develop CRISPR-Based POC COVID-19 Test Premium May 20, 2020 Mammoth Biosciences, GSK Developing CRISPR-Based SARS-CoV-2 Diagnostic for Home Testing Premium Apr 16, 2020 UCSF, Mammoth Bio Develop Rapid Coronavirus Diagnostic Using CRISPR-Cas12 Method Feb 21, 2020 Horizon Aims to Build Unique Portfolio of Gene Editing Tools While Avoiding IP Woes Premium Jan 30, 2020 Mammoth Biosciences Enters New Phase of Business Strategy With Horizon Deal, $45M Fundraise Premium Jan 13, 2020 Horizon Discovery, Mammoth Biosciences Sign Second CRISPR Tools Development Agreement Dec 20, 2019 People in the News: Gautam Kollu, Michael Bigda, Peter Nell, Ted Tisch, More Dec 13, 2019 Horizon Discovery, Mammoth Biosciences Team Up to Develop CRISPR Tools Mar 14, 2019 Mammoth Biosciences Licenses New CRISPR Enzyme for Disease Detection Applications Premium Breaking News NIH Earmarks $170M for All of Us Program's Personalized Nutrition Study Taiwanese Firm's IP Asserted in Suit Against Pacific Biosciences Found Partially Unpatentable In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm The Scan Transplant Tests Edited Pig Kidneys The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient. UK Changes Some Gene-Edited Crop Rules A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says. Pill Works Against Omicron in Lab Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports. Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.